Phase 3 Autism Spectrum Disorders Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Single Dose Double-blind, Placebo-controlled Cross-over (SDDBPCCO) Shiftability Study, Will be Followed by a 10-week Open-label Study With Arbaclofen (4 Weeks of Titration and Then 6 Weeks of Active/Stable Treatment). The Effects of Arbaclofen on Target EEG and ERG Metrics Will be Associated With th
Autism Spectrum Disorders
Hospital General Universitario Gregorio Marañon103 enrolled5 locationsNCT07655115
Completed
Phase 2Phase 3
A course of oxytocin nasal spray (OT) to treat social problems in youth with autism spectrum disorders
Autism Spectrum Disorders
University of Sydney50 enrolled1 locationACTRN12609000513213